Search results
Results From The WOW.Com Content Network
GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are “slated to make a big clinical impact."
The American Society of Health-System Pharmacists (ASHP) reported that 323 "active medication shortages" were reported in January–March 2024. As a result of drug scarcity, many healthcare systems were forced to either ration out essential drugs, triage patients based on the severity of their condition and their need for the drug, or both.
2024 could bring more effective ways to treat Alzheimer’s, schizophrenia, and hemophilia. ... 2023 was a strong year for innovative new drugs, with new medications for Alzheimer’s disease, ...
Omalizumab, sold under the brand name Xolair among others, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria (hives), [10] [11] and immunoglobulin E-mediated food allergy.
The Government Delegation for the National Plan on Drugs (Spanish: Delegación del Gobierno para el Plan Nacional sobre Drogas, DGPNSD) is the executive body of the Spanish Ministry of Health, attached to the Secretary of State for Health, which is responsible for the management, promotion, general coordination and supervision of the services in charge of updating and executing the National ...
Viatris was formed with the merger of Mylan and Pfizer's Upjohn business and has generic and key branded drugs in its portfolio, including erectile dysfunction drug Viagra, anti-anxiety medication ...
An experimental drug is a medicinal product (a drug or vaccine) that has not yet received approval from governmental regulatory authorities for routine use in human or veterinary medicine. A medicinal product may be approved for use in one disease or condition but still be considered experimental for other diseases or conditions.
A poster circa 2000 concerning cannabis in the United States.. The National Youth Anti-Drug Media Campaign is a current US government health education campaign by the Office of National Drug Control Policy (ONDCP) within the Executive Office of the President of the United States with the goal to "influence the attitudes of the public and the news media with respect to drug abuse" and of ...